mTOR: Role in cancer, metastasis and drug resistance

AK Murugan - Seminars in cancer biology, 2019 - Elsevier
Mammalian target of rapamycin (mTOR) is a serine/threonine kinase that gets inputs from
the amino acids, nutrients, growth factor, and environmental cues to regulate varieties of …

Non-canonical hedgehog signaling pathway in cancer: activation of GLI transcription factors beyond smoothened

S Pietrobono, S Gagliardi, B Stecca - Frontiers in genetics, 2019 - frontiersin.org
The Hedgehog-GLI (HH-GLI) pathway is a highly conserved signaling that plays a critical
role in controlling cell specification, cell–cell interaction and tissue patterning during …

Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer

M Mortazavi, F Moosavi, M Martini, E Giovannetti… - Critical reviews in …, 2022 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) has one of the worst prognoses among all
malignancies. PI3K/AKT/mTOR signaling pathway, a main downstream effector of KRAS is …

Targeting PI3K/AKT/mTOR signaling pathway in pancreatic cancer: from molecular to clinical aspects

S Stanciu, F Ionita-Radu, C Stefani, D Miricescu… - International journal of …, 2022 - mdpi.com
Although pancreatic cancer (PC) was considered in the past an orphan cancer type due to
its low incidence, it may become in the future one of the leading causes of cancer death …

Hedgehog signaling and truncated GLI1 in cancer

D Doheny, SG Manore, GL Wong, HW Lo - Cells, 2020 - mdpi.com
The hedgehog (HH) signaling pathway regulates normal cell growth and differentiation. As a
consequence of improper control, aberrant HH signaling results in tumorigenesis and …

Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases

S Mishra, SS Verma, V Rai, N Awasthee… - Cellular and Molecular …, 2019 - Springer
The long non-coding RNAs (lncRNAs) are the crucial regulators of human chronic diseases.
Therefore, approaches such as antisense oligonucleotides, RNAi technology, and small …

PI3K/Akt/mTOR signaling pathway in cancer stem cells

M Ebrahimi, E Nourbakhsh, AZ Hazara… - … -Research and Practice, 2022 - Elsevier
Cancer stem cells (CSCs) as a small subpopulation in tumor bulk are believed to initiate
tumor formation and are responsible for the resistance to cancer therapy. The proliferation …

Cancer stem cell signaling pathways

WH Matsui - Medicine, 2016 - journals.lww.com
Tissue development and homeostasis are governed by the actions of stem cells. Multipotent
cells are capable of self-renewal during the course of one's lifetime. The accurate and …

Target c-Myc to treat pancreatic cancer

M Ala - Cancer biology & therapy, 2022 - Taylor & Francis
ABSTRACT C-Myc overexpression is a common finding in pancreatic cancer and predicts
the aggressive behavior of cancer cells. It binds to the promoter of different genes, thereby …

Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development

H Zhao, J Wang, W Shao, C Wu, Z Chen, ST To, W Li - Molecular cancer, 2017 - Springer
Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary
tumor in the central nervous system. One of the most widely used chemotherapeutic drugs …